EFX
50
-5
MAR
65
-3
GRMN
46
-2
AMGN
33
2
GME
52
-2
JNPR
60
4
TXN
40
-9
PYPL
45
-7
EXPD
45
-3
MTCH
39
4
DE
40
-8
TAP
53
-4
FLR
55
-7
STI
7
-12
CINF
41
3
XRAY
23
-3
ADT
43
10
ISRG
60
-6
LRCX
42
-16
TSCO
58
-2
EFX
50
-5
MAR
65
-3
GRMN
46
-2
AMGN
33
2
GME
52
-2
JNPR
60
4
TXN
40
-9
PYPL
45
-7
EXPD
45
-3
MTCH
39
4
DE
40
-8
TAP
53
-4
FLR
55
-7
STI
7
-12
CINF
41
3
XRAY
23
-3
ADT
43
10
ISRG
60
-6
LRCX
42
-16
TSCO
58
-2
Financhill
Back

Bright Minds Biosciences 10K Form

Sell
50

DRUG
Bright Minds Biosciences

Last Price:
26.41
Seasonality Move:
-16.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DRUG News And Ratings

See the #1 stock for the next 7 days that we like better than DRUG

DRUG Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $193K
Price / Cash Flow: 0
Annual Sales: $1.00
Price / Book: 37.59

Profitability

EPS (TTM): -0.68110
Net Income (TTM): $-2.63M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Bright Minds Biosciences Earnings Forecast

Key Bright Minds Biosciences Financial Ratios

  • Per Share Earnings over the last 4 years have been positive in 1 years.

Bright Minds Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DRUG
Website: brightmindsbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DRUG Technical Analysis vs Fundamental Analysis

Sell
50
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy or a Sell?